Pharma Pressreleases

This section covers the managerial aspects in the Pharma industry.

Indonesian Pharma: Merck Sees Healthy Growth Ahead

Thursday, March 31, 2016
PR Newswire

JAKARTA Indonesia March 31 2016 PRNewswire Publicly listed Merck founded in 1970 as the Indonesian unit of a Germanbased pharmaceutical giant expects doubledigit growth in total sales in 2016 following a similar growth in its healthcare business last year The biopharma bu..

Brammer Bio Formed Through Merger of Brammer Biopharmaceuticals and Florida Biologix

Thursday, March 31, 2016
PR Newswire

LEXINGTON Mass and ALACHUA Fla March 31 2016 PRNewswire Brammer Biopharmaceuticals today announces its merger with Florida Biologix to create the bestinclass cell and gene therapy biologics contract development and manufacturing organization CDMO The merged company Brammer Bio will combine deep te..

Novel Multiple Myeloma Drug Aplidin(R) Shows Positive Results in Pivotal Phase 3 Study

Thursday, March 31, 2016
PR Newswire

SINGAPORE MADRID and MELBOURNE Australia March 31 2016 PRNewswire Internationalbiopharmaceutical company Specialised Therapeutics Asia Pte Ltd ST Asia will seek regulatory approvals for novel multiple myeloma drug Aplidin plitidepsin following the release of positive results in a pivotal Phase 3 ..

Origent Data Sciences and Cytokinetics Announce Research Collaboration on Predictive Analytics Model in ALS

Thursday, March 31, 2016
GLOBE NEWSWIRE

SOUTH SAN FRANCISCO Calif March 31 2016 GLOBE NEWSWIRE Origent Data Sciences Inc Origent and Cytokinetics Inc NasdaqCYTK today announced a research collaboration to refine and prospectively validate an Origent computer model to predict the course of ALS disease progression leveraging data from C..

Corium to Present at 15th Annual Needham Healthcare Conference

Thursday, March 31, 2016
GLOBE NEWSWIRE

MENLO PARK Calif March 31 2016 GLOBE NEWSWIRE Corium InternationalInc NasdaqCORI a commercialstage biopharmaceutical company focused on the development manufacture and commercialization of specialty transdermal products today announced that Peter Staple Coriums President and Chief Executive Of..

Karyopharm Receives NIAID Grant to Advance Development of KPT-350 for the Treatment of Lupus

Thursday, March 31, 2016
GLOBE NEWSWIRE

NEWTON Mass March 31 2016 GLOBE NEWSWIRE Karyopharm Therapeutics Inc NasdaqKPTI a clinicalstage pharmaceutical company today announced that it has been awarded a grant from the National Institute of Allergy and Infectious Disease NIAID to advance development of KPT350 an oral Selective Inhibit..

Repligen Forms Scientific Advisory Board

Thursday, March 31, 2016
GLOBE NEWSWIRE

WALTHAM Mass March 31 2016 GLOBE NEWSWIRE Repligen Corporation NASDAQRGEN a life sciences company focused on bioprocessing technology leadership today announced its formation of a Scientific Advisory Board SAB to provide thought leadership and oversight of the Companys innovation initiatives T..

AXIM Biotech CEO Appointed to American Pain Association Board of Advisors, Addresses American Opioid Abuse Epidemic

Thursday, March 31, 2016
GLOBE NEWSWIRE

NEW YORK March 31 2016 GLOBE NEWSWIRE Dr George E Anastassov MD DDS MBA and Chief Executive Officer of AXIM Biotechnologies Inc OTCAXIM was recently appointed to the American Pain Association APAs Board of Advisors AXIM Biotech holds more than 15 years of cannabisbased research and development k..

TransPerfect Medical Device Solutions Introduces EnCompass System for Digital Labeling

Thursday, March 31, 2016
GLOBE NEWSWIRE

NEW YORK March 31 2016 GLOBE NEWSWIRE TransPerfect the worlds largest provider of language services and content management technology to the medical device industry today announced the introduction of its EnCompass system for digital labeling and content management Built on validated technolog..

Sharecare Enlists Health Benefits Industry Execs To Scale Rapid Growth In Employer Market

Thursday, March 31, 2016
GLOBE NEWSWIRE

ATLANTA March 31 2016 GLOBE NEWSWIRE Sharecare a digital health and wellness engagement platform has appointed health industry veterans Howard Gruverman and Ken Goulet to scale the companys rapidly growing employer business With nearly 30 years serving the benefits industry and a focus on heal..

ClubM Rocks California with Statewide Delivery of Premium Medical Cannabis

Thursday, March 31, 2016
GLOBE NEWSWIRE

SAN DIEGO March 31 2016 GLOBE NEWSWIRE In 1996 California became the first state to establish a medical marijuana program setting off a tectonic shift in the legal and cultural landscape surrounding cannabis ..

PacBio’s SMRT Sequencing Provides Scientists with a Superior Gorilla Genome Reference

Thursday, March 31, 2016
GLOBE NEWSWIRE

MENLO PARK Calif March 31 2016 GLOBE NEWSWIRE Pacific Biosciences of California Inc NasdaqPACB the pioneer and leader in longread sequencing using its Single Molecule RealTime SMRT technology today announced that scientists from the University of Washington the McDonnell Genome Institute at Wa..

Medical Marijuana, Inc.’s HempMeds® Mexico Sponsors Cross-Border Forum, U.S. Representatives and Mexican Political Candidates Set to Discuss Rights to Patient Access

Thursday, March 31, 2016
GLOBE NEWSWIRE

SAN DIEGO March 31 2016 GLOBE NEWSWIRE Medical Marijuana Inc OTC PINKMJNA is proud to announce to shareholders and the public that portfolio company HempMeds Mexico is sponsoring a crossborder effort to discuss new perspectives on cannabis and legal access in Mexico Former California Assembl..

Akari Therapeutics Announces Positive Preliminary Results from First PNH Patient Treated With Coversin

Thursday, March 31, 2016
GLOBE NEWSWIRE

NEW YORK and LONDON March 31 2016 GLOBE NEWSWIRE Akari Therapeutics NASDAQAKTX an emerging growth developmentstage biopharmaceutical company announced today preliminary results from the first paroxysmal nocturnal hemoglobinuria PNH patient treated with subcutaneously administered Coversin The pa..

China Pharma Holdings, Inc. Reports Full Year 2015 Financial Results

Thursday, March 31, 2016
PR Newswire

HAIKOU China March 31 2016 PRNewswire China Pharma Holdings Inc NYSE MKT CPHI China Pharma the Company or We an NYSE MKT listed corporation with its fullyintegrated specialty pharmaceuticals subsidiary based in China today announced financial results for the year ended December 31 2015 Full Year..

ContraVir Pharmaceuticals Appoints John Cavan as Chief Financial Officer

Thursday, March 31, 2016
PR Newswire

EDISON NJ March 31 2016 PRNewswire ContraVir Pharmaceuticals Inc NASDAQ CTRV a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies announced today the appointment of John Cavan as Chief Financial Officer Mr Cavan had served as the Companys int..

SIR-Spheres® Y-90 Resin Microspheres Are a Well-Tolerated Alternative to Standard Therapies for Inoperable Primary Liver Cancer, New UK NICE Medtech Innovation Briefing Says

Thursday, March 31, 2016
PR Newswire

LONDON March 31 2016 PRNewswire Sirtex ASX SRX announced today that the UK National Institute for Health and Care Excellence NICE has issued a new Medtech Innovation Briefing MIB1stating that NHS doctors and commissioners may consider SIRSpheres Y90 resin microspheres as an alternative to standa..

Phase 3 Study Findings Demonstrate Treatment with Baricitinib Results in Significant Improvements for Patients with Rheumatoid Arthritis Who Had Inadequate Response to Biologics

Thursday, March 31, 2016
PR Newswire

INDIANAPOLIS March 31 2016 PRNewswire Eli Lilly and Company NYSE LLY and Incyte Corporation NASDAQ INCY announced that detailed results of RABEACON a pivotal phase 3 global study of baricitinib a oncedaily oral treatment currently under regulatory review for the treatment of moderatetosevere rhe..

ArmaGen Announces Initiation of Phase 2 Proof-of-Concept Clinical Trial in Brazil to Study AGT-181 for the Treatment of Hurler Syndrome

Thursday, March 31, 2016
PR Newswire

CALABASAS Calif March 31 2016 PRNewswire ArmaGen Inc a privately held biotechnology company focused on developing revolutionary therapies to treat severe neurological disorders announced today that the first patient has been dosed with AGT181 in a Phase 2 proofofconcept POC clinical trial treating..

Akcea Therapeutics Supports World Lipodystrophy Day

Thursday, March 31, 2016
PR Newswire

CAMBRIDGE Mass March 31 2016 PRNewswire Akcea Therapeutics a subsidiary of Ionis Pharmaceuticals NASDAQ IONS focused on developing and commercializing new treatments for serious cardiometabolic diseases recognizes World Lipodystrophy Day and has partnered with Lipodystrophy United lipodystrophyuni..

TOP